Furthermore, EIF4EBP1 acts as an oncogene in adenoid cystic carcinoma, bladder urothelial carcinoma, breast cancer (BRCA), KIRC, acute myeloid leukemia, liver hepatocellular carcinoma, lung adenocarcinoma, mesothelioma, and sarcoma. Here, EIF4EBP1 is linked to sarcoma.